$DCTH
Delcath Systems Inc

2016 Q1 Form 10-Q Financial Statement

#000156459016017679 Filed on May 04, 2016

View on sec.gov

Income Statement

Concept 2016 Q1 2015 Q1
Revenue $370.0K $444.0K
YoY Change -16.67% 43.23%
Cost Of Revenue $111.0K $133.0K
YoY Change -16.54% 43.01%
Gross Profit $259.0K $311.0K
YoY Change -16.72% 43.32%
Gross Profit Margin 70.0% 70.05%
Selling, General & Admin $2.377M $3.040M
YoY Change -21.81% -20.4%
% of Gross Profit 917.76% 977.49%
Research & Development $1.340M $979.0K
YoY Change 36.87% -32.81%
% of Gross Profit 517.37% 314.79%
Depreciation & Amortization $87.00K $196.0K
YoY Change -55.61% -21.29%
% of Gross Profit 33.59% 63.02%
Operating Expenses $3.721M $4.019M
YoY Change -7.41% -23.82%
Operating Profit -$3.462M -$3.708M
YoY Change -6.63% -26.7%
Interest Expense $5.000K $210.0K
YoY Change -97.62% -205.0%
% of Operating Profit
Other Income/Expense, Net -$28.00K $9.000K
YoY Change -411.11% -160.0%
Pretax Income -$1.810M -$3.490M
YoY Change -48.14% -33.9%
Income Tax
% Of Pretax Income
Net Earnings -$1.813M -$3.488M
YoY Change -48.02% -33.91%
Net Earnings / Revenue -490.0% -785.59%
Basic Earnings Per Share -$437.50
Diluted Earnings Per Share -$152500B -$574000B
COMMON SHARES
Basic Shares Outstanding 24.04M
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q1 2015 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $9.550M $18.46M
YoY Change -48.27% -40.93%
Cash & Equivalents $9.545M $18.46M
Short-Term Investments
Other Short-Term Assets $880.0K $840.0K
YoY Change 4.76% 166.67%
Inventory $840.0K $274.0K
Prepaid Expenses
Receivables $200.0K $312.0K
Other Receivables $0.00 $150.0K
Total Short-Term Assets $11.46M $20.03M
YoY Change -42.79% -39.94%
LONG-TERM ASSETS
Property, Plant & Equipment $1.070M $1.620M
YoY Change -33.95% -40.88%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.070M $1.620M
YoY Change -33.95% -40.66%
TOTAL ASSETS
Total Short-Term Assets $11.46M $20.03M
Total Long-Term Assets $1.070M $1.620M
Total Assets $12.53M $21.65M
YoY Change -42.12% -39.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $130.0K $268.0K
YoY Change -51.49% -18.79%
Accrued Expenses $1.490M $3.135M
YoY Change -52.47% 4.85%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.900M $4.239M
YoY Change -8.0% -31.74%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $770.0K $987.0K
YoY Change -21.99% 329.13%
Total Long-Term Liabilities $770.0K $5.226M
YoY Change -85.27% 2172.17%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.900M $4.239M
Total Long-Term Liabilities $770.0K $5.226M
Total Liabilities $4.670M $9.465M
YoY Change -50.66% 47.2%
SHAREHOLDERS EQUITY
Retained Earnings -$250.0M
YoY Change
Common Stock $122.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $51.00K
YoY Change 0.0%
Treasury Stock Shares $1.757K
Shareholders Equity $7.860M $16.42M
YoY Change
Total Liabilities & Shareholders Equity $12.53M $21.65M
YoY Change -42.12% -39.99%

Cashflow Statement

Concept 2016 Q1 2015 Q1
OPERATING ACTIVITIES
Net Income -$1.813M -$3.488M
YoY Change -48.02% -33.91%
Depreciation, Depletion And Amortization $87.00K $196.0K
YoY Change -55.61% -21.29%
Cash From Operating Activities -$3.820M -$4.410M
YoY Change -13.38% -1.78%
INVESTING ACTIVITIES
Capital Expenditures $15.00K $45.00K
YoY Change -66.67%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$20.00K -$50.00K
YoY Change -60.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 770.0K 2.480M
YoY Change -68.95% -44.89%
NET CHANGE
Cash From Operating Activities -3.820M -4.410M
Cash From Investing Activities -20.00K -50.00K
Cash From Financing Activities 770.0K 2.480M
Net Change In Cash -3.070M -1.980M
YoY Change 55.05% -19900.0%
FREE CASH FLOW
Cash From Operating Activities -$3.820M -$4.410M
Capital Expenditures $15.00K $45.00K
Free Cash Flow -$3.835M -$4.455M
YoY Change -13.92% -0.78%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3708000
CY2015Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-209000
CY2016Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-23000
CY2016Q1 us-gaap Cost Of Revenue
CostOfRevenue
111000
CY2015Q1 us-gaap Cost Of Revenue
CostOfRevenue
133000
CY2015Q1 us-gaap Gross Profit
GrossProfit
311000
CY2015Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3040000
CY2015Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
979000
CY2015Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
14000
CY2016Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-84000
CY2015Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-65000
CY2016Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-696000
CY2015Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-877000
CY2016Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-53000
CY2015Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
156000
CY2016Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
71000
CY2015Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-54000
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-3817000
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-4414000
CY2016Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15000
CY2015Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
45000
CY2016Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0
CY2015Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-15000
CY2015Q1 us-gaap Operating Expenses
OperatingExpenses
4019000
CY2016Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
8000
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-1813000
CY2016Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-86000
CY2016Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1805000
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
CY2016Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
23288697
CY2016Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
95000
CY2016Q1 us-gaap Restricted Stock Expense
RestrictedStockExpense
138000
CY2016Q1 us-gaap Depreciation
Depreciation
87000
CY2016Q1 dcth Interest Income Earned On Money Market And Operating Accounts
InterestIncomeEarnedOnMoneyMarketAndOperatingAccounts
2000
CY2015Q1 dcth Interest Income Earned On Money Market And Operating Accounts
InterestIncomeEarnedOnMoneyMarketAndOperatingAccounts
1000
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-45000
CY2016Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
767000
CY2015Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
2479000
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
767000
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
2479000
CY2016Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
3000
CY2015Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-27000
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3062000
CY2015Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2007000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20469000
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18462000
CY2016Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
183000
CY2015Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
820000
CY2016Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
245000
CY2015Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
0
CY2016Q1 dcth Maximum Percentage Of Prepaid Expenses And Other Current Assets
MaximumPercentageOfPrepaidExpensesAndOtherCurrentAssets
0.05
CY2015Q4 dcth Maximum Percentage Of Prepaid Expenses And Other Current Assets
MaximumPercentageOfPrepaidExpensesAndOtherCurrentAssets
0.05
CY2016Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4670000
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4638000
CY2016Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3600000
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3506000
CY2016Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
395000
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
692000
CY2016Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
372000
CY2015Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
481000
CY2016Q1 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
218000
CY2015Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
631000
CY2016Q1 dcth Maximum Percentage Of Current Liabilities Accrued
MaximumPercentageOfCurrentLiabilitiesAccrued
0.05
CY2015Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
220000
CY2016Q1 dcth Accrued Clinical Trial Expenses Current
AccruedClinicalTrialExpensesCurrent
230000
CY2015Q4 dcth Accrued Clinical Trial Expenses Current
AccruedClinicalTrialExpensesCurrent
219000
CY2016Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
508000
CY2016Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
353000
CY2015Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
360000
CY2016Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
326000
CY2015Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
251000
CY2016Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
156000
CY2015Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
146000
CY2016Q1 us-gaap Prepaid Insurance
PrepaidInsurance
441000
CY2015Q4 us-gaap Prepaid Insurance
PrepaidInsurance
625000
CY2016Q1 dcth Kits For Clinical Use
KitsForClinicalUse
238000
CY2015Q4 dcth Kits For Clinical Use
KitsForClinicalUse
162000
CY2015Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
173000
CY2015Q4 dcth Maximum Percentage Of Current Liabilities Accrued
MaximumPercentageOfCurrentLiabilitiesAccrued
0.05
CY2013 us-gaap Severance Costs1
SeveranceCosts1
5500000
CY2015Q4 us-gaap Restructuring Reserve
RestructuringReserve
1110000
CY2016Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
125000
CY2016Q1 us-gaap Restructuring Reserve
RestructuringReserve
985000
CY2013Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1300000
CY2013Q4 dcth Proceeds From Issuance Of Private Placement Gross
ProceedsFromIssuanceOfPrivatePlacementGross
7500000
CY2015Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
2500000
CY2015Q1 dcth Proceeds From Issuance Of Private Placement Gross
ProceedsFromIssuanceOfPrivatePlacementGross
2600000
CY2015Q3 us-gaap Partners Capital Account Units Sale Of Units
PartnersCapitalAccountUnitsSaleOfUnits
9400000
CY2015Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
9400000
CY2015Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6000000
CY2016Q1 dcth Number Of Inputs Used For Valuation Of Warrants
NumberOfInputsUsedForValuationOfWarrants
6
CY2015Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
3785000
CY2016Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-1672000
CY2016Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
2051000
CY2016Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11710331
CY2015Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2260320

Files In Submission

Name View Source Status
0001564590-16-017679-index-headers.html Edgar Link pending
0001564590-16-017679-index.html Edgar Link pending
0001564590-16-017679.txt Edgar Link pending
0001564590-16-017679-xbrl.zip Edgar Link pending
dcth-10q_20160331.htm Edgar Link pending
dcth-20160331.xml Edgar Link completed
dcth-20160331.xsd Edgar Link pending
dcth-20160331_cal.xml Edgar Link unprocessable
dcth-20160331_def.xml Edgar Link unprocessable
dcth-20160331_lab.xml Edgar Link unprocessable
dcth-20160331_pre.xml Edgar Link unprocessable
dcth-ex311_7.htm Edgar Link pending
dcth-ex312_9.htm Edgar Link pending
dcth-ex321_6.htm Edgar Link pending
dcth-ex322_8.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending